ReviewInternational journal of molecular sciences2017

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.

Daiji Kawanami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.